Inhibition of melanoma by survivin-specific lymphocytes combined with CCL17 and granulocyte-macrophage colony-stimulating factor in a mouse syngeneic model

Huang, L; Chen, GS; Chen, Y; Wu, WW; Tao, CL; Shao, HW; Huang, SL; Shen, H

Shen, H (corresponding author), Guangdong Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou 510006, Peoples R China.

ANTI-CANCER DRUGS, 2021; 32 (2): 138

Abstract

As a new generation of treatment, tumor immunotherapy targeting tumor-associated antigens (TAA) has attracted widespread attention. The survivin antig......

Full Text Link